



J. Afr. Ass. Physiol. Sci. 6 (2): 110-118, December 2018 
 
Journal of African Association of Physiological Sciences 







Moringa oleifera ameliorates nephropathic changes in alloxan-
induced diabetic adult wistar rats. 
 
H.B. Akpan, A.A. Akande, A.O. Ojewale, F.E. Oladipupo, O.F. Akinpelu and  S.O. 
Jimoh 






























Background: Diabetic nephropathy has been identified as a leading cause of chronic kidney 
disease which is a risk factor for kidney failure. Moringa oleifera (MO) is popularly known to 
possess various nutritional and health benefits. This study investigated the effects of crude 
aqueous extract of Moringa oleifera on the kidney of alloxan-induced diabetes in adult wistar 
rats. Methodology: Fifty six (56) adult wistar rats (150 – 200g) were randomly divided into 7 
groups (n=8) with group A as control  group,  while  animals  in groups B, C, D, E and F were 
induced with multiple dosage of alloxan monohydrate (100mg/kgbw) intraperitoneally. Group 
B served as the diabetic group and animals in groups C, D and  E  were  administered  100,  
300  and  500  mg/kgbw  of  MO respectively. Further, animals in group F which received 
Diabinese (15mg/kgbw) served as the pharmacological control group. Group G animals were 
given 100mg/kgbw of aqueous extract of MO before induction of diabetes. The parameters 
assessed in this study include animals’ weight, blood glucose levels, serum creatinine levels, 
and kidney histology. Results: The results showed that serum creatinine levels were increased 
as a result of diabetic nephropathy but reduced with MO administration. Histologically, kidney 
sections from the diabetic group presented with glomerular sclerosis, wide capsular spaces, 
thickening of Bowman’s capsule, tubular necrosis, focal areas of massive inflammatory cells 
infiltration and acellular material. MO treated groups showed glomeruli and tubules in various 
stages of tissue repair varied on a dose dependent basis, higher concentrations being more 
effective. Sections from animals pretreated with MO showed that Moringa oleifera appeared to 
have slowed the action of Alloxan on the kidney. Conclusion: This study, therefore, concluded 
that treatment with Moringa oleifera ameliorated the acute effects of alloxan-induced diabetic 
complications on renal microarchitecture and probably contributed to the restoration of 
morphology and hence the functions of the kidney in adult Wistar rats. 
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INTRODUCTION   
Diabetes mellitus (DM) is a metabolic disorder in the 
endocrine system resulting from a defect in insulin 
secretion, insulin action or both of them. DM 
contributes to several kinds of complications including 
diabetic retinopathy, nephropathy and neuropathy 
(Valmadrid et al., 2000). Notably is diabetic 
nephropathy which is the leading cause of chronic 
kidney disease in patients starting renal replacement 
therapy and is associated with increased cardiovascular 
mortality (Valmadrid et al., 2000). 
 
Diabetic nephropathy has been classically defined by 
the presence of proteinuria (protein levels exceeding 
>0.3g/24 h). This stage has been referred to as overt 
nephropathy, clinical nephropathy, proteinuria, or 
macro-albuminuria (Busko, 2006). In the early 1980s, 
seminal studies from Europe revealed that small 
amounts of albumin in the urine, not usually detected 
by conventional methods, were predictive of the later 
development of proteinuria in type 1 and type 2 
diabetic patients (Mogensen et al., 1984). This stage of 
renal involvement was termed microalbuminuria or 
incipient nephropathy. Many traditional plant 
treatments for diabetes are used throughout the world 
but most of the evidence for their beneficial effects is 
anecdotal. However, after the introduction of insulin 
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therapy the use of traditional treatment for diabetes 
greatly declined, although some traditional practices are 
continued for prophylactic purpose and adjuncts to 
conventional therapy (Udoamaka et al., 2013). In some 
societies there are strong desires to use herbs or plants 
for treatment, due to less side effects, easier 
consumption or availability and presumably low cost. 
However, very few of the traditional treatments for 
diabetes have received scientific or medical scrutiny 
and several have been shown to assist glycemic control 
in non-insulin dependent form of diabetes (Collier et 
al., 1987). 
 
Plants may act on blood glucose through different 
mechanisms; some of them may have insulin-like 
substances (Gray and Flatt, 1999), some may inhibit 
insulinase activity, others may hence increase beta cells 
proliferation in pancreas by activating regeneration of 
these cells (Abdel et al., 1997). The fiber of plants may 
also interfere with carbohydrate absorption, thereby 
affecting blood glucose (Nelson et al., 1991). In type-2 
diabetes, there is a gradual development of insulin 
resistance and beta cell dysfunction, strongly associated 
with obesity and a sedentary lifestyle (Haffner et al., 
2000). 
 
Moringa Oleifera (MO) belongs to Moringaceae family 
and is commonly known as Moringa or drumstick tree 
in English. Furthermore, in Nigeria, it is known by 
different names in various tribes, such as: Okwe oyibo 
in Igbo, Gwara or Habiwal in Hausa and Adagba 
maloye or Ewe Igbale in Yoruba. MO grows rapidly in 
most regions of Nigeria (Anwar et al., 2007). It can be 
used for water purification and hand washing, and is 
sometimes, also used in herbal medicine (Folkard et al., 
1999). Moringa oleifera is an important food 
commodity which has had enormous attention as the 
‘natural nutrition of the tropics’ (Anwar et al, 2007). Its 
anti-mutagenic, anti-tumour, anti-bacterial and anti-
inflammatory activities have been demonstrated 
(Siddhuraju and Becker, 2003). Its protective activity in 
simultaneous and post-treatment in relation to organ 
damage has also been demonstrated (Rajangam, 2001). 
For centuries and in many cultures around the world, 
the medicinal usage of  Moringa oleifera has been 
employed in the treatment of asthma, blackheads, blood 
impurities, bronchitis, catarrh, chest congestion, cholera 
and many other illnesses (Khawaja et al., 2010; Hamza, 
2010; Singh et al., 2012).  It has also long been labelled 
for its great cosmetic value and in recent years, it has 
commonly been found to be used in various health care 
products including body and hair moisturisers and 
conditioners (Anwar et al., 2007). It was also 
discovered that Moringa oleifera oil was used in skin 
ointments ever since the Egyptian times by “Trees for 
Life” organization and was claimed to be ‘the most 
nutrient-rich plant yet discovered’ by Khawaja et al. 
(2010). 
Nutritional composition of Moringa oleifera include 
many essential nutrients like, vitamins, minerals, amino 
acid, beta-carotene, antioxidants, anti-inflammatory 
nutrients and omega 3 and 6 fatty acid (Fahey, 2005; 
Hsu et al., 2006; Kasolo et al., 2010). These 
components have been reported to play essential roles 
in its medicinal and therapeutic properties (Al-Kharusi 
et al., 2009). In vitro and in vivo studies with the plant 
have recommended its effectiveness in treating 
inflammation, hyperlipidemia, and hyperglycemia 
(Fahey, 2005; Mbikay, 2012. 
Despite the widespread use of aqueous leaves extract of 
MO as a nutraceutical to manage DM and its 
complications, its protective effects on the renal system 
has not been elaborated. Therefore, the present study 
was designed to investigate some effects of aqueous 
crude extract of MO leaves on the kidney of alloxan - 
induced diabetes in adult wistar rats. 
 
 
MATERIALS AND METHODS  
 
Plant Material 
 Fresh Moringa oleifera leaves were collected from 
Twotees farm at Boluwaji, Ibadan, Nigeria. The plant 
was authenticated at the Forest Research Institute of 
Nigeria (FRIN), Ibadan and a voucher specimen was 
deposited in their herbarium with the herbarium 








The plant leaves were washed, air dried under shade 
and grinded into fine powder using an electric blender. 
The aqueous crude extract was prepared by extracting 
the powdered leaves (100g) with 1litre of distilled 
water in an electric shaker for 48 hours. After 48 hours, 
the extract was filtered through Whatman filter paper 
No. 4 and evaporated under reduced pressure using a 
rotary evaporator. The residue was kept in a bottle with 






All animal experiments were carried out under 
protocols approved by the Institutional Animal House 
of the Olabisi Onabanjo University, Ago-Iwoye, 
Nigeria. Fifty six rats ranging in weight from 150-200g 
of both sexes were used for this study.  These rats were 
randomly assigned to seven groups of eight (n=8) 
animals each as groups A, B, C, D, E F and G.  
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Acclimatization of experimental animals 
The animals were housed in plastic cages and 
acclimatized for a period of 2 weeks (14 days) in the 
research laboratory of the Faculty of Basic Medical 
Sciences, Olabisi Onabanjo University in strict 
compliance with the animal handling ethics of the 
University. This acclimatization was done to enable the 
rats adapt to their new environment before the 
commencement of the experiment. The rats were fed 
with rat feed and water ad libitum throughout the 
research period. 
 
Induction of Diabetes 
Alloxan was dissolved in 0.9% normal saline and 
diabetes was induced at 100mg/kg body weight by 
intraperitoneal injection of a freshly prepared solution. 
intraperitoneal injection of a freshly prepared solution. 
Animals in Groups B, C, D, E, F and G were induced. 
Induction was monitored by taking blood glucose level 
measurements at zero hour (prior to induction) and 
forty-eight (48) hours after induction. Animals with 
fasting glucose level greater then 200mg/dl after 48 
hours were considered diabetic. Thereafter, the animals 
were followed up for three weeks with a weekly 
assessment of the blood glucose levels. The blood 
sample was obtained by sequential snipping of the tail 
(Fluttert et al., 2000) and a glucometer (Accu-Check, 
by Roche, manufactured in USA) was used to measure 
the blood glucose levels using Accu-Check customized 
glucose strips.  
 
 









Diabinese  Duration 
(Days) 
A-Control             NO      42      NO     NO NO 
B-Alloxan             YES      42      NO     NO NO 
C-Alloxan+100mgMO             YES      21     100     NO 21 
D-Alloxan+300mgMO             YES      21     300     NO 21 
E-Alloxan+500mgMO             YES      21     500     NO 21 
F-Alloxan+Diabinese             YES      21     NO    YES 21 
G-100mgMO+Alloxan YES 
Post-   treated) 
     21  YES(Pre-treated)     NO 21 
 
 
 Intervention and administration of extract and drug  
After three (3) weeks of uninterrupted diabetic 
condition, animals in groups C, D and E were treated 
orally with graded doses of aqueous extract of MO at 
low dose (100mg/kgbw), medium dose (300mg/kgbw), 
and high dose of 500mg/kgbw respectively and to 
group F, Diabinese (15mg/kgbw) a conventional drug 
using orogastric gavage for another three (3) weeks. 
Diabinese served as the pharmacological control agent. 
Sacrifice and serum collection 
At the end of six acid weeks, all animals were 
sacrificed under exsanguination. Blood was collected 
by cardiac puncture with 5ml syringe and needle from 
the apex of the heart. The blood withdrawn was 
expelled into plain serum bottles and left for about 30 
minutes for the blood to properly clot before 
centrifugation. The blood was centrifuged for 10 
minutes at 4000 rpm to obtain a clear supernatant for 
serum creatinine analysis. The kidneys were thereafter 
harvested and immediately fixed in 10% Bouin’s fluid 
and processed for light microscopic studies. The 
processed sections of kidney were stained using 
Haematoxylene and Eosin (H&E) (Elias, 1974), 
Masson’s trichrome (MT) (Masson, 1929) and Periodic 
-Schiff (PAS) (McManus, 1948) staining technics.   
 
Serum creatinine assay.  
The Randox creatinine kit was used to determine 
creatinine according to the manufacturer’s instructions. 
Absorbance readings were taken using the 
spectrophotometer at a wavelength of 492 (490-
510nm). The working reagents were picric acid and 
sodium hydroxide and the principle is that creatinine in 
an alkaline solution reacts with picric acid to form a 
colored complex. The amount of formed is directly 
proportional to the creatinine concentration.  
 
Statistical Analysis 
The mean and standard deviation were calculated for 
all values and comparisons between the control and the 
treated groups were analyzed using One-way analysis 
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of variance (ANOVA) with the 16.0 version of SPSS 
package. Significance level was set at P<0.05  
 
RESULTS 
Average Animal Body Weight  
The average weight of animals in the alloxan treated 
groups C, D, E and F decreased during induction by 
24.32%, 19.13%, 19.78%, and 9.68% respectively. 
However, upon treatment, body weight increased by 
10.26%, 8.6%, 10.98% and 13.40% for the 
aforementioned groups respectively. In group A, there 
was 11.11% weight gain, while in group B, the 
negative control, 44.7% weight loss was recorded 
during the experiment (Fig.1). The treatment with MO 
ameliorated the impact of induced diabetes on the body 
weight and restored them to near normal levels with 
reference to control rat weights. This observation was 
however found to be dose- dependent. With graded 
doses of 100, 300 and 500 mg/kgbw of MO leaf 
aqueous extract, rats in the group that received the 
highest dose of 500mg/kgbw of MO leaf aqueous 
extract showed most significant weight gain compared 
to other treatment groups and the control. Group F that 
received 15mg/kgbw of diabinese showed high weight 
gain compared with group E. Furthermore, group G 
that received 100mg/kgbw of MO leaf aqueous extract 
before induction of diabetes showed a slow weight loss 
compared with groups that were treated with alloxan 
before intervention with MO leaf aqueous extract. MO 
contains calcium and iron that contribute to 




Fig. 1: Average weight (g) of the rats. INW = Initial weight; 
IND 3 = Induction week 4; FNW = Final weight: <** = 
significant decrease; **> = significant increase; ** = highly 
significant; * = slight significant difference                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 
Average Blood glucose level  
The graph below (figure 2) represents the blood 
glucose levels at three strategic points during the 
experiment viz: initial blood glucose level (INBGL), 
third week after alloxan administration (IND3) and the 
final blood glucose level (FNBGL) taken after three 
weeks of administration of MO extract. The results 
show that in all groups except the control 
administration of alloxan resulted in statistically 
significant increases (p<0.05) in blood glucose levels 
(*) of the rats during first three weeks when the animals 
remained in an uninterrupted hyperglycemic state. 
Administration of MO extract resulted in statistically 
significant decreases (p<0.05) in blood glucose levels 
(**) during the intervention period. However, in the 
diabetic control group in which animals did not receive 
any intervention agent, there was a highly significant 
elevation (p<0.05) in average blood glucose level (***) 
as a result of alloxan administration. In alloxan induced 
diabetic rats, the extract produced significant ant-
hyperglycemic effect, giving a percentage (p<0.05) 
reduction in blood sugar levels of 34.35%, 42.54% and 
58.27% for 100, 300 and 500 mg/kg doses respectively 
of the extract while diabinese exhibited 43.49% 




Fig. 2: Average blood glucose level of the rats. INBLG = 
initial blood glucose level; IND3 = induction week 3; 




Fig. 3: The bar chart of average serum creatinine level 
(mg/dl). Data expressed as Mean ± SEM p<0.05.  ** = 
highly significant increase compared with the control; *= 
significant decrease compared with alloxan group; *** = 
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highly significant decrease with reference to alloxan group; 
*ₐ    = no significant difference compared with control and 
diabinese groups (higher and lower respectively)  
Serum creatinine  
The serum creatinine level of all the treated groups 
significantly decreased (P<0.05) compared with group 
B (Fig. 3).  
 
Renal histoarchitecture 
In this study, sections from control group showed 
normal glomerulus (G), normal PCT (P) and normal 
DCT (D) (Plate 1A).The microscopic appearance of 
kidneys of alloxan-treated diabetic rats (Plate 1B) 
showed glomeruli with severe sclerosis (blue arrows) 
and wide capsular space (red arrow), The renal tubules 
showed some obvious cases of tubular necrosis 
affecting the proximal convoluted tubules (PCT) and 
distal convoluted tubules (DCT), with widened lumen 
(green arrows) as well as focal areas of massive 
inflammatory cells infiltration (INF – plate 1H). 
Sections of kidneys from animals treated with MO 
(Plates 1C, D, E and G) showed glomeruli (black 
arrows), PCTs (P) and DCTs (D) at various stages of 
restoration. Moringa pre-treated group showed a mild 
preservation of normal cellularity and reduced 




PLATE 1: A: Control showing normal glomerulus (G), 
normal PCT (P), normal DCT (D) H&E x400; B: Alloxan 
group – showing necrotic tubules (green arrows), glomerular 
sclerosis (blue arrows) H&E x400; C: Alloxan+100mgMO 
group H&E x400; D: Alloxan+300mgMO group H&E x400; 
E: Alloxan+500mgMO group H&E x400; F: 
Alloxan+Diabinese Diabinese (features comparable with 
control group) H&E x400; G: 100mgMO+alloxan H&E 
x400; H: Alloxan group showing inflammatory cell 
infiltration (INF). H&E x400; I: Moringa pre-treated group 
showing a mild preservation of normal cellularity and 
reduced inflammatory cell infiltration (B) H&E x400  
 
 
PLATE 2: Sections showing the microarchitecture of the 
kidney: A=Control showing normal glomerulus (G), normal 
PCT (P), normal DCT (D) MT x400; B: Alloxan group – 
showing necrotic tubule (red arrow), the deposit of a 
homogeneous, acellular material (yellow arrow) and 
increased interstitial material between the tubes (brown 
arrow). MT x400; C: Alloxan+100mgMO group MT x400; 
D: Alloxan+300mgMO group MT x400; E: 
Alloxan+500mgMO group MT x400; Groups C, D, E and G 
present glomeruli (black arrows, PCT- P and DCT-D at 
various stages of repair); F: Alloxan+Diabinese (features 
comparable with control group MT x400; G: 
100mgMO+alloxan, Moringa pre-treated group showing a 
mild preservation of normal kidney microarchitecture MT 
x400; H: Alloxan group showing sclerotic glomerulus (G), 
wide capsular space (yellow arrow). MT x400; I: Alloxan 
group showing sclerotic glomerulus (yellow arrow), widened 
DCT (red arrow), widened PCT (green double pointer 
arrow), and wide capsular space (brown arrow). MT x400. 
 
DISCUSSION: 
This present study demonstrated that alloxan 
successfully induced diabetes mellitus in the 
experimental animals and this was confirmed with the 
consistent rise in blood glucose level and after the 
intraperitoneal administration of alloxan into the 
experimental animals. 
The weight loss observed in this study appeared to be 
consistent with a previous report of the World Health 
Organization, that diabetes mellitus is often 
characterized by rapid and significant weight loss 
leading to fatigue which is not easily reversed (WHO, 
1985). This experiment showed that there was 
significant decrease in the body weight of the rats in all 
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the groups during the period of uninterrupted 
hyperglycaemic condition post-induction with AL; 
however, the trend appeared to have been slowed by 
 
 
PLATE 3: sections showing the microarchitecture of the 
kidney: A: Control showing normal glomerulus (G), normal 
PCT (P), normal DCT (D) PAS x400; B: Alloxan group – 
showing necrotic tubule (red arrow), the deposit of a 
homogeneous, acellular material (yellow arrow) and 
increased interstitial material between the tubes (brown 
arrow). PAS x400; C: Alloxan+100mgMO group PAS x400; 
D: Alloxan+300mgMO group PAS x400; E: 
Alloxan+500mgMO group PAS x400; Groups C, D, E and G 
present glomeruli (black arrows, PCT- P and DCT-D at 
various stages of repair); F: Alloxan+Diabinese (features 
comparable with control group PAS x400; G: 
100mgMO+alloxan, Moringa pre-treated group showing a 
mild preservation of normal cellularity PAS x400; H: 
Alloxan group showing sclerotic glomeruli (G), widened 
DCT (yellow arrow) and thickened basement membrane of 
Bowman’s capsule (red arrow). PAS x400; I: Alloxan group 
showing sclerotic glomerulus (green arrow), widened DCT 
(yellow arrow) and widened PCT (red arrow). PAS x400 
 
 
the intervention with MO. A pointer to the mechanism 
underlying the weight loss is the result of the 
investigations by Locatto et al., 1993 who reported that 
AL-treated rats showed an important reduction in body 
and bone mass, with a greater impact on soft tissues. 
The result obtained in this study is also in agreement 
with Viswanathaswamy et al., (2011), who reported 
that alloxan-induced diabetes significantly decreased 
the body weight of diabetic untreated rats as the study 
duration increased compared with the treated groups 
and normal control rats. Furthermore, with the 
compromised carbohydrate metabolism (Akpan et al., 
2007, 2017), there is evidence of having to draw energy 
from stored sources in the body thereby impacting 
significantly on the animal body weight.  
Glucose is a major fuel for animal cells. It is supplied 
to the organism through dietary carbohydrates and, 
endogenously, through hepatic gluconeogenesis and 
glycogenolysis (Gylfe et al., 2014). Glucose absorption 
from the gastrointestinal tract (GIT) into blood is 
regulated by a variety of neuronal signals and 
enterohormones (incretins), as well as by meal 
composition and the intestinal flora (Owens et al., 
2013). Glucose homeostasis reflects a balance between 
glucose supply and its utilization. Physiologically, this 
balance is determined by the level of circulating insulin 
and tissue responsiveness to it. It stimulates glucose 
uptake and utilization by tissues, especially by liver, 
skeletal muscle, and adipose tissue (Owens et al., 2013; 
Gylfe et al., 2014). Insulin is secreted by pancreatic 
islet β cells (Owens et al., 2013).  Medicinal plants 
attract growing interest in the therapeutic management 
of diabetes mellitus. The present study assessed the 
probable anti-diabetic effects of an aqueous extract of 
MO leaves in treating alloxan-induced diabetic Wistar 
rats. The reduction of blood glucose level in this 
experiment confirmed reports that the active 
compounds of MO have strong glucose lowering 
potential (Jain et al., 2010; Abd El Latif et al., 2014, 
Sangkitikomol et al., 2014 and Yassa & Tohamy, 
2014). The extract showed a dose dependent effect 
since more pronounced anti-hyperglycemic effect was 
observed with increase in dosage. Tight control of 
blood sugar level has been found to be the major factor 
in preventing micro albuminuria which if left 
unattended would progress to macro albuminuria and 
subsequently, end stage renal disease.  
From the results obtained, it could be inferred that 
Moringa olejfera had effects comparable with the 
reference drug diabinese. The comparable effects of 
MO with diabinese on hyperglycemic animals suggests 
similar modes of action. Alloxan destroys the 
pancreatic β-cells which implies that fewer of these 
cells will be available to elaborate insulin needed to aid 
the removal of glucose from the blood milieu. The 
result of this is the accumulation of glucose in the 
blood which leads to the hyperglycaemic state observed 
in alloxan-treated animals. However, in this study, the 
extract successfully lowered blood sugar levels in rats 
previously administered alloxan, an indication that the 
extract has pro-pancreatic effects. Earlier studies by 
Malviya et al. (2010), reported that the therapeutic 
actions of alkaloids, flavonoids, saponins, and tannins, 
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as found in MO, were additive in the context of their 
collective capacities to exert glycemic control and anti-
hyperglycemic capabilities. The polyphenolic 
proanthocyanidin, commonly referred to as condensed 
tannin, has also been reported to exhibit considerable 
antidiabetic properties (Xie, 2005; Yokozawa et al., 
2012). According to Yokozawa et al., 2012, 
proanthocyanidin protected STZ-diabetic rats against 
hyperglycemia and related disorders as well as 
hyperlipidemia through modulation of general 
metabolism. These previous findings corroborate the 
outcomes of the current study in which previously 
hyperglycemic rat had lowered blood glucose levels 
following administration of MO extract.  
 
The very high blood creatinine level as observed in the 
alloxan group was probably the result of diabetic 
nephropathy which is considered a major complication 
of diabetes (Sayed et al., 2012). The implication is that 
the ability of the kidney to filter creatinine from the 
blood is somewhat impeded which allow the product to 
remain in the blood. Diabetic nephropathy is a clinical 
syndrome characterized by persistent albuminuria, 
progressive decline in the glomerular filtration rate 
(GFR), and elevated arterial blood pressure (Kanwar et 
al., 2008). However, treatment of experimentally 
diabetic rats with MO extract revealed a dose-
dependent decrease in the serum creatinine level, an 
indication of an enhanced functionality of the kidneys 
of these animals. Creatinine is not reabsorbed into the 
body from the kidneys. Hence, any failure on the part 
of the kidneys to excrete creatinine results in rise of 
creatinine levels in the blood. Variations from normal 
creatinine levels could indicate kidney dysfunction and 
muscle problems 
Compromise in PCT microstructure translates to 
impaired function of about seventy-five percent water 
reabsorption from the glomerular filtrate. This, 
obviously, is the mechanism underlying the frequent 
urination experienced in the diabetic condition. Sodium 
reabsorption coupled with hydrogen and potassium 
secretion is compromised in DCT necrosis and these 
have adverse effects in the general well-being of 
diabetics. Sections stained with PAS showed thickened 
glomerular basement membrane and lack of brush 
boarders in the tubules, in agreement with Yassin et al., 
(2004) who noticed that in diabetic rats the glomerular 
tufts were obviously contracted, lobulated, degenerated 
and infiltrated by chronic inflammatory cells and 
RBCs. The glomeruli were more or less shrunken and 
the urinary space became wide. According to Yanardag 
et al., 2002, the treatment of rats with alloxan showed 
some histopathological changes in the kidney in the 
form of degeneration, inflammation, necrosis, 
mesangial hyper cellularity and deformed renal tissue 
architecture. Also, Selvant et al. (2008) reported that in 
diabetic rats the kidney showed degenerative changes 
in cortex, medulla and necrosis of tubules. In addition 
Zeeuw et al., (2006) observed that in diabetics, the 
kidney sections showed damaged glomeruli, proximal 
tubules and interstitial inflammation. The foregoing, 
which are in agreement with the findings of this study, 
underlie major anatomical disruptions in the kidney 
structure and are pointers to gradual deterioration in the 
physiological capability of this very important organ in 
the body of the animals. 
  
Significant restructuring which include increase in 
animal body weight, reduction in blood glucose level, 
regeneration in the glomeruli, DCT and PCT among 
others were observed following the treatment of rats 
with MO extract. These observations also followed a 
dose-dependent pattern and agree with the findings of 
Ndong et al., 2007, Kumbhare et al., 2012, Yassa & 
Tohamy, 2014 and Parikh et al., 2014, who separately, 
noticed that the radical scavenging effect of MO was 
found to be increased with increasing concentrations. 
Also, Abdulraham et al., 2015 reported the antidiabetic 
activity of the higher dose of Moringa seeds powder to 
be more efficient than that of a lower dose.  
 
These ameliorative effects as observed in this study 
could be attributed to the availability of the active 
beneficial constituents present in MO leaf (Vongsak et 
al., 2013).  
The antioxidant activity of MO leaf powder is due to its 
content of phenolics and flavonoids that have 
scavenging effect on free radicals (Ghiridhari et al., 
2011). MO contains three classes of phytochemicals, 
viz: glucosinolates such as glucomoringin, flavonoids 
such as quercetin and kaempferol, and phenolic acids 
such as chlorogenic acid; all of these classes have 
medicinal benefits (Mbikay et al., 2012). These three 
phytochemical groups of MO possess antioxidant, 
hypoglycemic, hypotensive, antidyslipidemic, 
anticancer, and anti-inflammatory properties (Lako et 
al., 2007) and would likely have contributed to the 
restoration of weight and blood glucose levels observed 
in this study.  
 
CONCLUSION 
This study, therefore, concluded that treatment with 
Moringa oleifera ameliorated the acute effects of 
alloxan-induced diabetic complications on renal 
microarchitecture and probably contributed to the 
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restoration of morphology and hence the functions of 
the kidney in adult Wistar rats. 
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